
The zzso zzso of zzso and zzso by zzso zzso in Multiple zzso trial was a zzso randomized, zzso phase III, zzso study of zzso in zzso patients from 22 centers in 9 countries with clinically zzso or zzso zzso multiple zzso The patients were zzso to receive zzso zzso zzso 22 zzso (6 zzso 44 zzso (12 zzso or zzso given zzso three times weekly for 2 zzso All patients underwent zzso zzso zzso magnetic resonance imaging scans to determine the overall magnetic resonance imaging disease activity and burden of disease, and a cohort of 205 patients had 11 initial monthly zzso zzso and zzso magnetic resonance imaging zzso Over the 2 years, the zzso group showed a progressive median increase in burden of disease of zzso whereas the zzso group and zzso group showed median decreases of zzso and zzso zzso The number of zzso active zzso and percentage of scans showing zzso activity on the zzso scans were also significantly reduced in both treatment groups compared with zzso with a clear zzso favoring the zzso dose over the zzso zzso In the zzso undergoing initial monthly zzso this reduction in activity became statistically significant 2 months after the start of zzso These results provide strong, objective evidence to support the positive clinical results of reduction in relapses and delay in disease zzso In addition, they also demonstrate a significant dosage effect, favoring the zzso zzso 

